transplantation and was still four times in the Background. The determinators of patient survival remaining years. after renal transplantation are incompletely known, Conclusion. In the present study, time-related changes and conflicting results have been reported. This may in patient management were responsible for improved have been influenced by time-related changes in patient patient survival in the first year after transplantation selection, post-transplantation management and during the study period. Many individual factors conimmunosuppressive regimens. This study was per-tributed moderately to the risk of mortality after the formed to evaluate in recipients of a first renal trans-first year. Compared to the general population the plant the eÂect of patient characteristics, trans-mortality rate of renal transplant recipients was signiplantation era, and the immunosuppressive regimen ficantly higher during the whole follow-up period. on patient survival. Methods. We used data from the Leiden Renal Key words: age; azathioprine; cyclosporin; diabetes Transplant Database of all first renal transplantations mellitus; dialysis; era; hypertension; immunosuppresperformed between 1966 and 1994 in Leiden, the sion; renal transplantation; survival analysis Netherlands. The eÂect of the following parameters on mortality was investigated: era of transplantation, sex, age at transplantation, cause of renal failure, immunosuppressive regimen, type and duration of pretransplantation dialysis, hypertension, diabetes mellitus, and smoking. In addition we analysed the causes of death. Introduction
Statistical methods

Subjects and methods
The crude mortality rates per 100 person years of follow up In the Leiden Renal Transplant Database pre-and post-were calculated in the various separate categories. Mortality transplantation patient characteristics and follow-up data to all causes was also compared to the expected mortality have been recorded prospectively for all renal and combined obtained as an average of the death rates in the general renal-pancreas transplantations, performed in the University Dutch population during the follow-up period, standardized Hospital of Leiden, the Netherlands since 1966. We used this for age, sex and calendar period (standardized mortality database as the primary source of information. Where neces-ratio). The 95% confidence limits of the standardized mortalsary, data were supplemented from the transplantation charts ity ratio were calculated under the assumption that the or Eurotransplant data.
variance of the observed mortality follows a Poisson distribution. The cumulative survival was estimated with the productlimit method ( Kaplan-Meier). To quantify the diÂerent Subjects determinants for death and to adjust for possible confounding variables, we used a Cox proportional hazard This study was restricted to first renal transplants. Cadaver and living donor kidney transplantations were separately model. Dummy variables were created for all determinants, with the first category as reference category. Statistical analysed. All patients were followed until 1 January 1994. Mortality was separately determined within and after the analysis was performed using the PYRS and SPSS software packages. first year post-transplantation. Graft failure was defined as the need for renal function replacement therapy, from any cause. Because the follow-up of patients after the occurrence of graft failure was incompletely recorded in the Database, Results such patients were regarded as withdrawn alive at the time of graft failure. In all other cases the patient was assumed Of the 1098 first renal transplantations performed to be lost to follow-up.
between 1966 and 1994, 96 cases were lost to followThe cause of death was classified as due to ( 1) remaining 86 cases were living donor kidney recipients, The eÂect of the following parameters on mortality was including 8 deaths (9%), 12 graft failures ( 14%), and investigated: ( 1) Era of transplantation; the period of interest 66 patients ( 77%) with follow-up to 1 January 1994. was divided into four periods: [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] [1974] [1975] [1976] [1977] [1978] [1979] [1980] [1981] [1982] [1983] , The 86 living donors consisted of four identical twins, 1984-1989, and 1990-1994 after. After adjustment for age and sex in a multivariate Cox model, the relative risk of mortality for living was found in the highest age category. The disproportionally low mortality rate in patients transplanted at donor transplant recipients compared with cadaver transplant recipients was 0.5 ( 95% CI 0.2 to 1.0, P= an age lower than 40 years is explained by an overrepreesentation of patients with a very long follow-up 0.06). The relative risk was 0.7 ( 95% CI 0.2 to 2.1, P=0.5) for mortality in the first year and 0.5 (95% CI time (i.e. low mortality).
Because the age at transplantation and sex were 0.2 to 1.1, P=0.1) thereafter. strongly related to the post-transplantation risk of mortality, although only so after the first year, adjustMortality rate in relation to sex and age at ment for age and sex was made in all of the following transplantation analyses. The 916 cadaver kidney transplantations were performed in 558 men ( 61%) and 358 women (39%). Underlying cause of renal failure Survival was better in women. For both sexes the crude mortality rate for the first post-transplantation year In roughly half of the 916 first cadaver kidney transplant recipients the cause of renal failure was primary was double the rate for the remaining follow up period ( Table 1 ) . Compared to men, women had lower mor-glomerulonephritis or autosomal dominant polycystic kidney disease (Table 2 ). The mean age at transplantatality both in the first year post-transplantation and during the long-term follow-up (P=0.03).
tion and the sex distribution diÂered considerably between the diagnostic categories. The high percentage For all age categories the crude first-year mortality rates were roughly similar (comparison, P=NS). In of women with miscellaneous causes of renal failure was due to a disproportionately large number of contrast, the relative risk of mortality after the first year increased significantly over age (P<0.0001 for women with chronic pyelonephritis (75/358 women vs 25/558 men), analgesic nephropathy (23/358 women comparison of all categories), but no further increase vs 12/558 men) and systemic lupus erythematosus long-term survival of patients transplanted in the era [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] [1974] . After a mean follow-up of 25 years, the ( 12/358 women vs 6/558 men).
true survival of patients transplanted before 1974 was The cause of renal failure had no significant eÂect 44%. In addition, survival of patients with a funcon the risk of mortality in the first year after transtioning graft overestimates overall survival of transplantation (comparison, P=NS). Compared with planted patients, because mortality after graft loss is glomerulonephritis, the relative risk of mortality after high. When death after graft failure was included in the first year was diÂerent for the other causes of renal the analysis, the estimated 25-year survival of patients failure (P=0.0001 for comparison of all categories), transplanted before 1974 was 36%. being highest for patients with diabetes mellitus or Before 1983, the immunosuppressive regimen for nephrosclerosis, and lowest for patients with miscellanfirst cadaver kidney transplantations consisted of azaeous known causes. thioprine and prednisone. From 1983 onwards it consisted of cyclosporin and prednisone, but in 71 of these Era of transplantation and immunosuppressive regimen patients cyclosporin was replaced by azathioprine at 3-6 months post-transplantation (conversion group). The mean age (SD) at transplantation increased from
The relative risk of first year mortality was significantly 33.4 ( 11.6) years in the era 1966-1974 to 48.3 (13.1) lower in patients receiving cyclosporin and in the in the years 1990-1994. The sex distribution remained conversion group compared with patients treated with similar in all eras. The crude first-year mortality rate azathioprine only (P=0.009). After addition of the era decreased from 10.2 to 2.6/100 person-years from 1966 of transplantation into this model, the eÂect of to 1994 onwards, whereas the mortality rate after the immunosuppression on the risk of mortality was no first year remained essentially unchanged at about longer statistically significant. 3.0/100 person-years (Table 3 ).The relative risk of firstyear mortality was significantly related to the trans-Type and duration of dialysis plantation era and was highest in the early phase of transplantation (P=0.03). The overall Kaplan-Meier's Mortality in patients treated with peritoneal dialysis (n=82) before transplantation was not diÂerent from survival curve (Figure 1 ) may overestimate the true mortality in patients treated with haemodialysis (n= Death patterns 665 ) (relative risk 1.0, 95% CI 0.2 to 5.2, P=1.0 for Compared to the general Dutch population, mortality the first year of follow-up; relative risk 0.3, 95% CI in recipients of a first cadaver kidney transplant was 0.1 to 1.4, P=0.1 for the remaining follow-up period ). higher in the first year after transplantation, the standIn the 665 patients who underwent only haemodialysis ardized mortality ratio being 14.7 (95% confidence the age at transplantation was positively correlated interval 10.2-19.2) ( Table 5 ). The standardized morwith the duration of prior haemodialysis (P<0.0001). tality ratio after the first year was still 4.4 (95% No significant additional eÂect of the duration of confidence interval: 3.6-5.2). The standardized mortalhaemodialysis on the risk of post-transplantation mor-ity ratio for cardiovascular death was elevated to a tality was detected. similar extent within the first year and after the first year. The standardized mortality ratio for death caused by malignancy was significantly elevated only after the Hypertension, smoking, and diabetes mellitus first year. As population death rates for infectious Hypertension, smoking, and diabetes mellitus had no causes of death were not available the standardized significant eÂect on the first year mortality. Smoking mortality ratio for infections could not be calculated and diabetes were associated with a higher risk of separately. However, the standardized mortality ratio mortality for the follow-up episode after 1 year (P= for non-cardiovascular and non-malignant causes of 0.002 and P=0.04 respectively) ( Table 4 ). In hyper-death in the first year was most markedly elevated and tensive patients a similar trend was identified, but this half of the observed deaths (14/29) in this category were caused by infection. was just not statistically significant (P=0.06). *RR, relative risk of mortality; CI, confidence interval. The relative risks were estimated in a Cox proportional hazards model, adjusting for age and sex. †In 804 patients the smoking histories were known. ‡ In 822 patients data on the use of antihypertensive medication were known. 
